U.K. starts construction on cell line manufacturing facility; Orlando area offers incentives for sterile manufacturing facility;

> The Cell Therapy Catapult in the U.K. has started construction on its £55 million ($84 million) cell and gene therapy manufacturing site in Stevenage. Release

> Pharmapack Europe looks to wrap up the award nomination process. Release

> Florida's Osceola County wants to give $640,000 in incentives to "Project Genuine" to attract an unnamed sterile injectables maker to the Orlando area. Story

Suggested Articles

Recipharm has been building its capabilities in sterile injectable and inhalation drugs. Now it is buying a CDMO that manufactures devices for both.

The FDA has slapped the parent of Dollar Tree stores with a warning letter saying some CMOs that made its OTC products were among the world's worst.

GSK expects Shingrix supplies to rise slightly in 2020, but the real "step change" will come in 2024 with a brand-new manufacturing facility.